393 related articles for article (PubMed ID: 31437429)
1. Novel repair mechanisms in a renal ischaemia/reperfusion model: Subsequent saxagliptin treatment modulates the pro-angiogenic GLP-1/cAMP/VEGF, ANP/eNOS/NO, SDF-1α/CXCR4, and Kim-1/STAT3/HIF-1α/VEGF/eNOS pathways.
Kamel NM; Abd El Fattah MA; El-Abhar HS; Abdallah DM
Eur J Pharmacol; 2019 Oct; 861():172620. PubMed ID: 31437429
[TBL] [Abstract][Full Text] [Related]
2. Dipeptidyl peptidase-4 inhibition improves cardiac function in experimental myocardial infarction: Role of stromal cell-derived factor-1α.
Connelly KA; Advani A; Zhang Y; Advani SL; Kabir G; Abadeh A; Desjardins JF; Mitchell M; Thai K; Gilbert RE
J Diabetes; 2016 Jan; 8(1):63-75. PubMed ID: 25565455
[TBL] [Abstract][Full Text] [Related]
3. Houshiheisan promotes angiogenesis via HIF-1α/VEGF and SDF-1/CXCR4 pathways: in vivo and in vitro.
Xiang Y; Yao X; Wang X; Zhao H; Zou H; Wang L; Zhang QX
Biosci Rep; 2019 Oct; 39(10):. PubMed ID: 31652450
[TBL] [Abstract][Full Text] [Related]
4. Protective effect of saxagliptin against renal ischaemia reperfusion injury in rats.
Tekin S; Beytur A; Cakir M; Taslıdere A; Erden Y; Tekin C; Sandal S
Arch Physiol Biochem; 2022 Jun; 128(3):608-618. PubMed ID: 31979992
[TBL] [Abstract][Full Text] [Related]
5. Gene transfer of stromal cell-derived factor-1alpha enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularization.
Hiasa K; Ishibashi M; Ohtani K; Inoue S; Zhao Q; Kitamoto S; Sata M; Ichiki T; Takeshita A; Egashira K
Circulation; 2004 May; 109(20):2454-61. PubMed ID: 15148275
[TBL] [Abstract][Full Text] [Related]
6. Hydroxysafflor yellow A promotes neovascularization and cardiac function recovery through HO-1/VEGF-A/SDF-1α cascade.
Wei G; Yin Y; Duan J; Guo C; Zhu Y; Wang Y; Xi M; Wen A
Biomed Pharmacother; 2017 Apr; 88():409-420. PubMed ID: 28122306
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-668-3p Protects Against Oxygen-Glucose Deprivation in a Rat H9c2 Cardiomyocyte Model of Ischemia-Reperfusion Injury by Targeting the Stromal Cell-Derived Factor-1 (SDF-1)/CXCR4 Signaling Pathway.
Gao Z; Gao Q; Lv X
Med Sci Monit; 2020 Jan; 26():e919601. PubMed ID: 31997826
[TBL] [Abstract][Full Text] [Related]
8. Effects of trimetazidine on the Akt/eNOS signaling pathway and oxidative stress in an in vivo rat model of renal ischemia-reperfusion.
Mahfoudh-Boussaid A; Hadj Ayed Tka K; Zaouali MA; Roselló-Catafau J; Ben Abdennebi H
Ren Fail; 2014 Oct; 36(9):1436-42. PubMed ID: 25246344
[TBL] [Abstract][Full Text] [Related]
9. Danshensu accelerates angiogenesis after myocardial infarction in rats and promotes the functions of endothelial progenitor cells through SDF-1α/CXCR4 axis.
Yin Y; Duan J; Guo C; Wei G; Wang Y; Guan Y; Mu F; Yao M; Xi M; Wen A
Eur J Pharmacol; 2017 Nov; 814():274-282. PubMed ID: 28864209
[TBL] [Abstract][Full Text] [Related]
10. Lipopolysaccharide-induced cross-tolerance against renal ischemia-reperfusion injury is mediated by hypoxia-inducible factor-2α-regulated nitric oxide production.
He K; Chen X; Han C; Xu L; Zhang J; Zhang M; Xia Q
Kidney Int; 2014 Feb; 85(2):276-88. PubMed ID: 24025643
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-inducible factor-1α dependent pathways mediate the renoprotective role of acetazolamide against renal ischemia-reperfusion injury.
An Y; Zhang JZ; Han J; Yang HP; Tie L; Yang XY; Xiaokaiti Y; Pan Y; Li XJ
Cell Physiol Biochem; 2013; 32(5):1151-66. PubMed ID: 24335166
[TBL] [Abstract][Full Text] [Related]
12. Glucose-independent renoprotective mechanisms of the tissue dipeptidyl peptidase-4 inhibitor, saxagliptin, in Dahl salt-sensitive hypertensive rats.
Uchii M; Kimoto N; Sakai M; Kitayama T; Kunori S
Eur J Pharmacol; 2016 Jul; 783():56-63. PubMed ID: 27063445
[TBL] [Abstract][Full Text] [Related]
13. MK-0626, a dipeptidyl peptidase-4 inhibitor, improves neovascularization by increasing both the number of circulating endothelial progenitor cells and endothelial nitric oxide synthetase expression.
Shih CM; Chen YH; Lin YW; Tsao NW; Wu SC; Kao YT; Chiang KH; Li CY; Chang NC; Lin CY; Huang CY; Lin FY
Curr Med Chem; 2014 Jun; 21(17):2012-22. PubMed ID: 24059225
[TBL] [Abstract][Full Text] [Related]
14. The dipeptidyl peptidase-4 inhibitor saxagliptin improves function of circulating pro-angiogenic cells from type 2 diabetic patients.
Poncina N; Albiero M; Menegazzo L; Cappellari R; Avogaro A; Fadini GP
Cardiovasc Diabetol; 2014 May; 13():92. PubMed ID: 24886621
[TBL] [Abstract][Full Text] [Related]
15. Effects of ischemic preconditioning in the late phase on homing of endothelial progenitor cells in renal ischemia/reperfusion injury.
Bo CJ; Chen B; Jia RP; Zhu JG; Cao P; Liu H; Wu R; Ge YZ; Wu JP
Transplant Proc; 2013 Mar; 45(2):511-6. PubMed ID: 23498786
[TBL] [Abstract][Full Text] [Related]
16. Saxagliptin restores vascular mitochondrial exercise response in the Goto-Kakizaki rat.
Keller AC; Knaub LA; Miller MW; Birdsey N; Klemm DJ; Reusch JE
J Cardiovasc Pharmacol; 2015 Feb; 65(2):137-47. PubMed ID: 25264749
[TBL] [Abstract][Full Text] [Related]
17. The DPP-4 inhibitor saxagliptin ameliorates ox-LDL-induced endothelial dysfunction by regulating AP-1 and NF-κB.
Ma S; Bai Z; Wu H; Wang W
Eur J Pharmacol; 2019 May; 851():186-193. PubMed ID: 30639312
[TBL] [Abstract][Full Text] [Related]
18. Combination of stromal-derived factor-1alpha and vascular endothelial growth factor gene-modified endothelial progenitor cells is more effective for ischemic neovascularization.
Yu JX; Huang XF; Lv WM; Ye CS; Peng XZ; Zhang H; Xiao LB; Wang SM
J Vasc Surg; 2009 Sep; 50(3):608-16. PubMed ID: 19595531
[TBL] [Abstract][Full Text] [Related]
19. Ischemic preconditioning reduces endoplasmic reticulum stress and upregulates hypoxia inducible factor-1α in ischemic kidney: the role of nitric oxide.
Mahfoudh-Boussaid A; Zaouali MA; Hadj-Ayed K; Miled AH; Saidane-Mosbahi D; Rosello-Catafau J; Ben Abdennebi H
J Biomed Sci; 2012 Jan; 19(1):7. PubMed ID: 22252226
[TBL] [Abstract][Full Text] [Related]
20. Effects of warm ischaemia combined with cold preservation on the hypoxia-inducible factor 1α pathway in an experimental renal autotransplantation model.
Delpech PO; Thuillier R; Le Pape S; Rossard L; Jayle C; Billault C; Goujon JM; Hauet T
Br J Surg; 2014 Dec; 101(13):1739-50. PubMed ID: 25331755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
